Digital sequence information (DSI) is a placeholder term used in international policy fora, particularly the Convention on Biological Diversity (CBD), to refer to data derived from dematerialized genetic resources (GR).
The 2018 Ad Hoc Technical Expert Group on DSI reached consensus that the term was "not appropriate". [1] Nevertheless, the term is generally agreed to include nucleic acid sequence data, and may be construed to include other data types derived from or linked to dematerialized genetic resources, including, for example, protein sequence data. [2] [3] The appropriateness and meaning of this term remain controversial as evidenced by its continued placeholder status, post the 15th Conference of the Parties to the CBD. [4] [5] [6] DSI is crucial to research in a wide range of contexts, including public health, medicine, biodiversity, plant and animal breeding, and evolution research.
The Nagoya Protocol, a component of the Convention on Biological Diversity, establishes a right for countries to regulate, and to share in benefits derived from, their nation's genetic resources by arranging Access and Benefit Sharing Agreements with users. Academic researchers, however, generally share DSI freely and openly online, following a set of principles that align with the open science movement. [5] Open sharing of DSI is recognized to have broad benefits, and open science is a major and growing focus of international science policy. [7] [8] This creates a perceived conflict with benefit sharing obligations, as individuals can access and use these open data without entering into benefit-sharing agreements.
Parties to the Convention on Biological Diversity have considered a range of policy options that strike different balances between these two important international policy goals. [4] At COP 15, parties agreed to establish a multilateral mechanism for benefit-sharing from the use of DSI. [9] At COP 16, parties agreed to implement this by establishing a fund to which commercial users of DSI would be expected to contribute a percent of their revenue (see COP 16 below).
In May 2024, [10] a WIPO Diplomatic Conference concluded the International Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (GRATK) [11] , which mandates disclosure requirements for patents based on genetic resources (GR). [12] [13]
Some observers to the negotiations claim that, under the final wording of the treaty, the disclosure requirements apply to patents based on DSI, as long as the DSI was necessary to the patented invention, and/or the invention depends on the specific properties of the DSI:
The draft versions of the Treaty previously contemplated mentions of the qualifier “direct” in the trigger. Drafts also contemplated mentions of the qualifier “material,” both in the trigger itself and in its definition. These qualifiers were deleted by the drafters, leaving only the criteria of necessity and dependence on specific properties. If a GR was necessary to create a claimed invention, and the invention depends on such GR, even if indirectly and/or immaterially, it falls under the scope of this Treaty. A claimed invention relying on DSI obtained from a GR will therefore have to disclose the GR from which the DSI derives. [14]
At the 2024 United Nations Biodiversity Conference of the Parties to the CBD in Cali (COP16), a decision was made to establish the Cali Fund, to which industries that use DSI, like pharma, cosmetics, nutraceuticals, and biotech, will be expected to contribute a small portion of their profits to support global biodiversity conservation. [15] A methodology for implementation, including thresholds and contribution rates, is scheduled to be agreed at the seventeenth conference of the parties to the CBD. The fund will support biodiversity protection and reward Indigenous and forest communities, with 50% allocated to local and Indigenous groups. [16]
DSI is also an important concept in other international legally binding instruments with access and benefit-sharing obligations, including:
The Convention on Biological Diversity (CBD), known informally as the Biodiversity Convention, is a multilateral treaty. The Convention has three main goals: the conservation of biological diversity ; the sustainable use of its components; and the fair and equitable sharing of benefits arising from genetic resources. Its objective is to develop national strategies for the conservation and sustainable use of biological diversity, and it is often seen as the key document regarding sustainable development.
A patent is a type of intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. In most countries, patent rights fall under private law and the patent holder must sue someone infringing the patent in order to enforce their rights.
The World Intellectual Property Organization is one of the 15 specialized agencies of the United Nations (UN). Pursuant to the 1967 Convention Establishing the World Intellectual Property Organization, WIPO was created to promote and protect intellectual property (IP) across the world by cooperating with countries as well as international organizations. It began operations on 26 April 1970 when the convention entered into force. The current Director General is Singaporean Daren Tang, former head of the Intellectual Property Office of Singapore, who began his term on 1 October 2020.
Bioprospecting is the exploration of natural sources for small molecules, macromolecules and biochemical and genetic information that could be developed into commercially valuable products for the agricultural, aquaculture, bioremediation, cosmetics, nanotechnology, or pharmaceutical industries. In the pharmaceutical industry, for example, almost one third of all small-molecule drugs approved by the U.S. Food and Drug Administration (FDA) between 1981 and 2014 were either natural products or compounds derived from natural products.
The International Treaty on Plant Genetic Resources for Food and Agriculture is a comprehensive international agreement in harmony with the Convention on Biological Diversity, which aims at guaranteeing food security through the conservation, exchange and sustainable use of the world's plant genetic resources for food and agriculture (PGRFA), the fair and equitable benefit sharing arising from its use, as well as the recognition of farmers' rights. It was signed in 2001 in Madrid, and entered into force on 29 June 2004.
Rio Convention relates to the following three conventions, which were agreed at the Earth Summit held in Rio de Janeiro in June 1992.
The International Union for the Protection of New Varieties of Plants or UPOV is a treaty body with headquarters in Geneva, Switzerland. Its objective is to provide an effective system for plant variety protection. It does so by defining a blueprint regulation to be implemented by its members in national law. The expression UPOV Convention also refers to one of the three instruments that relate to the union, namely the 1991 Act of the UPOV Convention, 1978 Act of the UPOV Convention and 1961 Act of the UPOV Convention with Amendments of 1972.
Traditional knowledge (TK), indigenous knowledge (IK), folk knowledge, and local knowledge generally refers to knowledge systems embedded in the cultural traditions of regional, indigenous, or local communities.
The Biodiversity Indicators Partnership (BIP) brings together a host of international organizations working on indicator development, to provide the best available information on biodiversity trends to the global community. The Partnership was initially established to help monitor progress towards the Convention on Biological Diversity (CBD) 2010 Biodiversity target. However, since its establishment in 2006 the BIP has developed a strong identity not only within the CBD but with other Multilateral Environmental Agreements (MEAs), national and regional governments and other sectors. As a result, the Partnership will continue through international collaboration and cooperation to provide biodiversity indicator information and trends into the future.
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity, also known as the Nagoya Protocol on Access and Benefit Sharing (ABS), is a 2010 supplementary agreement to the 1992 Convention on Biological Diversity (CBD). Its aim is the implementation of one of the three objectives of the CBD: the fair and equitable sharing of benefits arising out of the utilization of genetic resources, thereby contributing to the conservation and sustainable use of biodiversity. It sets out obligations for its contracting parties to take measures in relation to access to genetic resources, benefit-sharing and compliance.
The National Biodiversity Authority (NBA) is a statutory autonomous body under the Ministry of Environment, Forests and Climate Change, Government of India established in 2003 to implement the provisions under the Biological Diversity Act, 2002, after India signed Convention on Biological Diversity (CBD) in 1992.
The Biological Diversity Act, 2002 is an Act by the Parliament of India for the preservation of biological diversity in India, and provides the mechanism for equitable sharing of benefits arising out of the use of traditional biological resources and knowledge. The Act was enacted to meet the obligations under the Convention on Biological Diversity, because India is a signatory to the treaty.
Plant genetic resources describe the variability within plants that comes from human and natural selection over millennia. Their intrinsic value mainly concerns agricultural crops.
The status of Cannabis in international law refers to the series of dispositions in international law affecting States' sovereignty in relation to the Cannabis plant genus, to a variety of "cannabis products" derived from the plant, or to their synthetic analogs.
Biopiracy is the unauthorized appropriation of knowledge and genetic resources of farming and indigenous communities by individuals or institutions seeking exclusive monopoly control through patents or intellectual property. While bioprospecting is the act of exploring natural resources for undiscovered chemical compounds with medicinal or anti-microbial properties, commercial success from bioprospecting leads to the company's attempt at protecting their intellectual property rights on indigenous medicinal plants, seeds, genetic resources, and traditional medicines.
The Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore is in charge of negotiating one or several international legal instruments (treaty) to protect traditional knowledge, traditional cultural expressions, and genetic resources in relation with intellectual property, thus bridging existing gaps in international law. The IGC is convened in Geneva by the World Intellectual Property Organization (WIPO), and has been meeting regularly since 2001.
The 2022 United Nations Biodiversity Conference of the Parties (COP15) to the UN Convention on Biological Diversity (CBD) was a conference held in Montreal, Canada, which led to the international agreement to protect 30% of land and oceans by 2030 and the adoption of the Kunming-Montreal Global Biodiversity Framework.
The Kunming-Montreal Global Biodiversity Framework (GBF) is an outcome of the 2022 United Nations Biodiversity Conference. Its tentative title had been the "Post-2020 Global Biodiversity Framework". The GBF was adopted by the 15th Conference of Parties (COP15) to the Convention on Biological Diversity (CBD) on 19 December 2022. It has been promoted as a "Paris Agreement for Nature". It is one of a handful of agreements under the auspices of the CBD, and it is the most significant to date. It has been hailed as a "huge, historic moment" and a "major win for our planet and for all of humanity."
The 2024 United Nations Biodiversity Conference of the Parties (COP16) to the UN Convention on Biological Diversity (CBD) was a conference that was held from October 21 to November 1, 2024 in Cali, Colombia. The monitoring framework agreed at the previous conference should allow the progress of the countries towards national goals and targets under the Kunming-Montreal Global Biodiversity Framework to be evaluated.
The WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge or GRATK Treaty is an international legal instrument to combat biopiracy through disclosure requirements for patent applicants whose inventions are based on genetic resources and/or associated traditional knowledge.